ArticleEndocrinology and metabolism (Seoul, Korea)2020

Glycemic Efficacy and Metabolic Consequences of an Empagliflozin Add-on versus Conventional Dose-Increasing Strategy in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea.

Yujin Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.